Stock listing

NASDAQ:AIMT Aimmune Therapeutics Inc Stock

Follow Aimmune Therapeutics Inc into a list and get an email when it puts out news.

Last close · NASDAQ:AIMT

$34.49 USD

Close on Oct 13, 2020 · No longer trades

Aug 5, 2015 to last close +115.6% · weekly closes, Aug 5, 2015 – Oct 13, 2020
Lowest – highest close
$10.26 – $39.55 USDSince Aug 5, 2015 · lowest Jul 7, 2016 · highest Dec 22, 2017

Delisted NASDAQ:AIMT no longer trades. Its last trading date is unknown. Company history and updates stay available on this page.

Ticker
NASDAQ:AIMT
Asset type
Stock
Exchange
NASDAQ
Currency
USD

Aimmune Therapeutics Inc on 6ix

Decks
4 decks · latest Jun 18, 2019

Decks

DeckKindSlidesDate
Investor Presentation (June 2019)Investor deck36 slidesJun 18, 2019
Corporate Update (November 2018)Corporate update31 slidesNov 19, 2018
Technical Presentation (February 2018)Technical13 slidesFeb 20, 2018
J.P. Morgan Healthcare Conference January 2017Conference22 slidesJan 9, 2017

Open Decks

People

6ix reads each seat by machine from the page it links to, and can misread one.

PersonSeat
Mark Iwicki
Other companies: Inhibikase Therapeutics, Inc. (Chief Executive Officer - Inhibikase · Since at least Feb 14, 2025); Q32 Bio Inc. (Director · Since at least Mar 25, 2024); Third Harmonic Bio Inc. (Director · Since at least Sep 14, 2022); Akero Therapeutics Inc (Director · Since at least Jun 19, 2019); Kala Bio, Inc. (Director · Since at least Jul 19, 2017); Jade Biosciences, Inc. (Director · Apr 2, 2021 – Jun 5, 2024 · Past); Pulmatrix, Inc. (Director · Mar 20, 2017 – Jan 28, 2021 · Past)
Director · May 25, 2016 – Oct 10, 2020 · Past
Stephen George Dilly
Other companies: Codexis, Inc. (Director · Since at least Jun 16, 2020); Sierra Oncology Inc (CEO and President, Director · Jun 1, 2020 – Jul 1, 2022 · Past); Sangamo Therapeutics, Inc. (Director · Jun 12, 2013 – May 18, 2020 · Past)
President and CEO, Director · Aug 5, 2015 – Jun 11, 2018 · Past
Brett K Haumann
Other companies: Theravance Biopharma, Inc. (Chief Medical Officer · May 14, 2014 – Feb 20, 2021 · Past)
Director · Oct 31, 2018 – Oct 10, 2020 · Past
Stacey Denenberg Seltzer
Other companies: OnKure Therapeutics, Inc. (Director · Apr 8, 2021 – Jun 6, 2023 · Past)
Director · Aug 5, 2015 – Oct 10, 2020 · Past
Daniel C Md AdelmanChief Medical Officer · Jun 16, 2016 – Oct 10, 2020 · Past
Mary M RozenmanSee Remarks · Aug 5, 2015 – Dec 31, 2019 · Past
Robert Myles ElfontChief Medical Officer · Aug 5, 2015 – Feb 26, 2016 · Past

Open People

Log in to ask 6ix AI your own questions about Aimmune Therapeutics Inc.